Kenneth Waggoner

Kenneth Waggoner

Company: PharmaCyte Biotech

Job title: CEO, President & General Counsel


Examining Microencapsulation Methods for Implantation 11:45 am

• Introduction to microencapsulation technology and product pipeline • Manufacturing process of encapsulated cells • Unique attributes of encapsulation material • Placement of capsules and mechanism of action • Development of bio-artificial pancreas to treat Type 1 and insulin-dependent Type 2 diabetes by encapsulating genetically engineered liver cells, stem cells and beta islet cellsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.